Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-04

Clinical Trial Update: HPP737 Substance Balance Study in Human [NA]

View source ↗

Summary

Clinical trial update for a substance balance study of HPP737 in humans for psoriasis; the study has not yet begun recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HPP737

Snippet

Sponsor: Newsoara Biopharma Co., Ltd. | Conditions: Psoriasis | NA | Status: NOT_YET_RECRUITING